Niagen Bioscience, Inc. (NAGE) Stock Forecast & Price Target
Niagen Bioscience, Inc. · NASDAQ
$3.11-0.06 (-1.89%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Niagen Bioscience, Inc, 2 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $10.00 to $11.00, so the covering firms are broadly aligned. The average target of $10.50 sits 238% above the current $3.11. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.01 next quarter toward $0.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Strong Buy
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Niagen Bioscience, Inc.
As of Sep, 2 of 2 firms rate NAGE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NAGE EPS & revenue forecast
EPS · NEXT QUARTER
$0.01
Range $0.01 – $0.01 · 1 analysts · -64% YoY
Next period, 1 analysts expect Niagen Bioscience, Inc. to earn $0.01 a share (range $0.01 – $0.01), versus $0.03 a year earlier. Full-year consensus is $0.09, growing to $0.10 the year after.
REVENUE · NEXT QUARTER
$38.1M
Range $36.0M – $39.8M · 1 analysts · +13% YoY
Revenue is expected to reach $38.1M (range $36.0M – $39.8M), +12.6% year-over-year. Full-year consensus is $133.1M, rising to $155.3M next year.
Top analysts covering Niagen Bioscience, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NAGE.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #312
Buy
$11.00+253.7% to target
Overall win rate
36%
+ Follow
#2
Sean McGowan
Roth MKM · Rank #391
Buy
$12.00+285.9% to target
Overall win rate
27%
+ Follow
#3
Susan Anderson
Canaccord Genuity · Rank #411
Buy
$10.00+221.5% to target
Overall win rate
29%
+ Follow
#4
IZ
Ilya Zubkov
Freedom Capital Markets
Buy
$9.00+189.4% to target
Coverage
—
+ Follow
NAGE stock forecast FAQ
What is NAGE's average 12-month price target?+
The 2 analysts with a live target average $10.50 for Niagen Bioscience, Inc. over the next 12 months, ranging from a $11.00 high to a $10.00 low.
Is NAGE stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 2 analyst ratings, 2 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NAGE?+
The Street-high target is $11.00 (HC Wainwright & Co.), and the Street-low is $10.00 (Canaccord Genuity). The average of all 2 active targets is $10.50.
How many Wall Street analysts cover NAGE?+
2 analysts have an active rating on Niagen Bioscience, Inc., and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering NAGE?+
Among analysts who currently cover NAGE, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #312). Their current call is Buy with a $11.00 target.
What is Niagen Bioscience, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.01 per share (range $0.01 – $0.01) across 1 analysts. Full-year EPS is projected at $0.09, rising to $0.10 the following year.
How much revenue is Niagen Bioscience, Inc. expected to report next quarter?+
Consensus revenue is $38.1M (range $36.0M – $39.8M). Full-year revenue is projected at $133.1M, growing to $155.3M next year.
Have analysts been upgrading or downgrading NAGE lately?+
As of Sep, 2 of 2 firms rate NAGE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NAGE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
